Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Federal prosecutors dropped all charges against the 2 remaining Stryker Biotech sales managers charged with illegal off-label promotion and of lying to the FDA.
A federal grand jury indicted 10 individuals related to 2 schemes to defraud Medicare that cost the health care program more than $2 million in false claims for durable medical equipment.
As traditionally high margins erode and hospitals consolidate their purchasing operations, what can medical device makers do to adapt their business models? Boston Consulting Group thinks it has the answer.